Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Uzawa, Akiyuki ^a   Mori, Masahiro ^a   Hayakawa, Sei ^a   Masuda, Saeko ^a   Nomura, Fumio ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; FLUORESCEIN ISOTHIOCYANATE; CHEMOKINE RECEPTOR;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PERIPHERAL LYMPHOCYTE; REMISSION; TH1 CELL; TH2 CELL; AGED; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST;

ADULT; AGED; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RECEPTORS, CHEMOKINE; STATISTICS, NONPARAMETRIC;

EID: 78149320987     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-113     Document Type: Article

References (22)

1. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338:436-45. 10.1056/NEJM199802123380706, 9459648.
2. Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999, 103:807-15. 10.1172/JCI5150, 408141, 10079101.
3. Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999, 96:6873-8. 10.1073/pnas.96.12.6873, 22009, 10359806.
4. Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N, Takase S, Itoyama Y. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol 2001, 114:207-12. 10.1016/S0165-5728(00)00456-2, 11240033.
5. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999, 11:81-8. 10.1093/intimm/11.1.81, 10050676.
6. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-9. 10.1212/01.wnl.0000216139.44259.74, 16717206.
7. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-7. 10.1084/jem.20050304, 2212860, 16087714.
8. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-205. 10.1093/brain/awl371, 17282996.
9. Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009, 66:425-8. 10.1002/ana.21753, 19798642.
10. Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y, Minohara M, Murai H, Mihara F, Taniwaki T, Kira J. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005, 128:988-1002. 10.1093/brain/awh453, 15743872.
11. Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J Neurol 2009, 256:2082-4.
12. Uzawa A, Mori M, Hayakawa S, Masuda S, Kuwabara S. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol 2010, 17:672-6. 10.1111/j.1468-1331.2009.02897.x, 20039942.
13. Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T, Kuwabara S. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008, 196:181-7. 10.1016/j.jneuroim.2008.03.009, 18462810.
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-7. 10.1002/ana.1032, 11456302.
15. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998, 187:129-34. 10.1084/jem.187.1.129, 2199181, 9419219.
16. Wu XM, Osoegawa M, Yamasaki K, Kawano Y, Ochi H, Horiuchi I, Minohara M, Ohyagi Y, Yamada T, Kira JI. Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J Neurol Sci 2000, 177:24-31. 10.1016/S0022-510X(00)00322-1, 10967179.
17. Wang HY, Matsui M, Araya S, Onai N, Matsushima K, Saida T. Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis. J Neurol Sci 2003, 216:61-6. 10.1016/S0022-510X(03)00214-4, 14607304.
18. Kobayashi N, Kondo T, Takata H, Yokota S, Takiguchi M. Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3. J Leukoc Biol 2006, 80:320-9. 10.1189/jlb.1205725, 16861617.
19. Shi Z, Okuno Y, Rifa'i M, Endharti AT, Akane K, Isobe K, Suzuki H. Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur J Immunol 2009, 39:2106-19. 10.1002/eji.200939314, 19609979.
20. Narikawa K, Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol 2004, 149:182-6. 10.1016/j.jneuroim.2003.12.010, 15020078.
21. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133:349-61. 10.1093/brain/awp309, 20047900.
22. Elovaara I, Kuusisto H, Paalavuo R, Särkijärvi S, Lehtimäki T, Huhtala H, Vilpo J. Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation. Acta Neurol Scand 2006, 113:163-6. 10.1111/j.1600-0404.2005.00566.x, 16441245.